Literature DB >> 17604175

Synthesis and pharmacochemical evaluation of novel aryl-acetic acid inhibitors of lipoxygenase, antioxidants, and anti-inflammatory agents.

E Pontiki1, D Hadjipavlou-Litina.   

Abstract

Lipoxygenase catalyzes the first two steps of the transformation of arachidonic acid into leukotrienes which are implicated in host defense reactions. It is well known that many acids possess potent anti-inflammatory activity. Taking into account that compounds bearing a thienyl, naphthyl, pyrollyl, and 2,4-di-tert-butyl-phenol moieties possess anti-inflammatory activity which is related to their capacity to transfer electrons and to scavenge reactive oxygen species, we synthesized some new aryl-acetic acids and we explored their ability to inhibit soybean lipoxygenase, to present antioxidant and anti-inflammatory activities, and to interact with glutathione. The compounds have shown important antioxidant activity, medium anti-inflammatory activity, and very good inhibition of soybean lipoxygenase. Compound 3-(3,5-di-tert-butyl-2-hydroxy-phenyl)-2-phenyl-acrylic acid (1i) showed significant in vitro LO inhibition (IC(50) 65 microM). The results are discussed in terms of structural and physicochemical characteristics of the compounds. The structures of the synthesized compounds were confirmed by spectral and elemental analysis. Their lipophilicity are experimentally determined by RPTLC method.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604175     DOI: 10.1016/j.bmc.2007.06.001

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  9 in total

1.  Design, synthesis and evaluation of PD176252 analogues for ameliorating cisplatin-induced nephrotoxicity.

Authors:  Sen Yao; Biao Wei; Mingjun Yu; Xiaoming Meng; Meng He; Risheng Yao
Journal:  Medchemcomm       Date:  2019-04-11       Impact factor: 3.597

2.  Pteridine-2,4-diamine derivatives as radical scavengers and inhibitors of lipoxygenase that can possess anti-inflammatory properties.

Authors:  Eleni Pontiki; Dimitra Hadjipavlou-Litina; Alexandros Patsilinakos; Trang M Tran; Charles M Marson
Journal:  Future Med Chem       Date:  2015-10-01       Impact factor: 3.808

3.  Gaultheria trichophylla (Royle): a source of minerals and biologically active molecules, its antioxidant and anti-lipoxygenase activities.

Authors:  Fiaz Alam; Qazi Najam Us Saqib; Mohammad Ashraf
Journal:  BMC Complement Altern Med       Date:  2017-01-03       Impact factor: 3.659

4.  Multifunctional Cinnamic Acid Derivatives.

Authors:  Aikaterini Peperidou; Eleni Pontiki; Dimitra Hadjipavlou-Litina; Efstathia Voulgari; Konstantinos Avgoustakis
Journal:  Molecules       Date:  2017-07-25       Impact factor: 4.411

5.  Multitarget molecular hybrids of cinnamic acids.

Authors:  Aikaterini Peperidou; Dorothea Kapoukranidou; Christos Kontogiorgis; Dimitra Hadjipavlou-Litina
Journal:  Molecules       Date:  2014-12-02       Impact factor: 4.411

6.  Multi-Target Cinnamic Acids for Oxidative Stress and Inflammation: Design, Synthesis, Biological Evaluation and Modeling Studies.

Authors:  Eleni Pontiki; Dimitra Hadjipavlou-Litina
Journal:  Molecules       Date:  2018-12-20       Impact factor: 4.411

7.  2-Arylidene-1-indandiones as Pleiotropic Agents with Antioxidant and Inhibitory Enzymes Activities.

Authors:  Olympia Kouzi; Eleni Pontiki; Dimitra Hadjipavlou-Litina
Journal:  Molecules       Date:  2019-12-03       Impact factor: 4.411

8.  Synthesis and Biological Evaluation of Novel Hybrid Molecules Containing Purine, Coumarin and Isoxazoline or Isoxazole Moieties.

Authors:  Michael G Kallitsakis; Angelo Carotti; Marco Catto; Aikaterini Peperidou; Dimitra J Hadjipavlou-Litina; Konstantinos E Litinas
Journal:  Open Med Chem J       Date:  2017-11-30

9.  Novel cinnamic acid derivatives as antioxidant and anticancer agents: design, synthesis and modeling studies.

Authors:  Eleni Pontiki; Dimitra Hadjipavlou-Litina; Konstantinos Litinas; George Geromichalos
Journal:  Molecules       Date:  2014-07-07       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.